Cargando…
Cancer treatment data available in European cancer registries: Where are we and where are we going?
Population-based cancer registries are responsible for collecting incidence and survival data on all reportable neoplasms within a defined geographical area. During the last decades, the role of cancer registries has evolved beyond monitoring epidemiological indicators, as they are expanding their a...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944949/ https://www.ncbi.nlm.nih.gov/pubmed/36845700 http://dx.doi.org/10.3389/fonc.2023.1109978 |
_version_ | 1784892032478609408 |
---|---|
author | Giusti, Francesco Martos, Carmen Trama, Annalisa Bettio, Manola Sanvisens, Arantza Audisio, Riccardo Arndt, Volker Francisci, Silvia Dochez, Carine Ribes, Josepa Fernández, Laura Pareja Gavin, Anna Gatta, Gemma Marcos-Gragera, Rafael Lievens, Yolande Allemani, Claudia De Angelis, Roberta Visser, Otto Van Eycken, Liesbet |
author_facet | Giusti, Francesco Martos, Carmen Trama, Annalisa Bettio, Manola Sanvisens, Arantza Audisio, Riccardo Arndt, Volker Francisci, Silvia Dochez, Carine Ribes, Josepa Fernández, Laura Pareja Gavin, Anna Gatta, Gemma Marcos-Gragera, Rafael Lievens, Yolande Allemani, Claudia De Angelis, Roberta Visser, Otto Van Eycken, Liesbet |
author_sort | Giusti, Francesco |
collection | PubMed |
description | Population-based cancer registries are responsible for collecting incidence and survival data on all reportable neoplasms within a defined geographical area. During the last decades, the role of cancer registries has evolved beyond monitoring epidemiological indicators, as they are expanding their activities to studies on cancer aetiology, prevention, and quality of care. This expansion relies also on the collection of additional clinical data, such as stage at diagnosis and cancer treatment. While the collection of data on stage, according to international reference classification, is consolidated almost everywhere, data collection on treatment is still very heterogeneous in Europe. This article combines data from a literature review and conference proceedings together with data from 125 European cancer registries contributing to the 2015 ENCR-JRC data call to provide an overview of the status of using and reporting treatment data in population-based cancer registries. The literature review shows that there is an increase in published data on cancer treatment by population-based cancer registries over the years. In addition, the review indicates that treatment data are most often collected for breast cancer, the most frequent cancer in women in Europe, followed by colorectal, prostate and lung cancers, which are also more common. Treatment data are increasingly being reported by cancer registries, though further improvements are required to ensure their complete and harmonised collection. Sufficient financial and human resources are needed to collect and analyse treatment data. Clear registration guidelines are to be made available to increase the availability of real-world treatment data in a harmonised way across Europe. |
format | Online Article Text |
id | pubmed-9944949 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99449492023-02-23 Cancer treatment data available in European cancer registries: Where are we and where are we going? Giusti, Francesco Martos, Carmen Trama, Annalisa Bettio, Manola Sanvisens, Arantza Audisio, Riccardo Arndt, Volker Francisci, Silvia Dochez, Carine Ribes, Josepa Fernández, Laura Pareja Gavin, Anna Gatta, Gemma Marcos-Gragera, Rafael Lievens, Yolande Allemani, Claudia De Angelis, Roberta Visser, Otto Van Eycken, Liesbet Front Oncol Oncology Population-based cancer registries are responsible for collecting incidence and survival data on all reportable neoplasms within a defined geographical area. During the last decades, the role of cancer registries has evolved beyond monitoring epidemiological indicators, as they are expanding their activities to studies on cancer aetiology, prevention, and quality of care. This expansion relies also on the collection of additional clinical data, such as stage at diagnosis and cancer treatment. While the collection of data on stage, according to international reference classification, is consolidated almost everywhere, data collection on treatment is still very heterogeneous in Europe. This article combines data from a literature review and conference proceedings together with data from 125 European cancer registries contributing to the 2015 ENCR-JRC data call to provide an overview of the status of using and reporting treatment data in population-based cancer registries. The literature review shows that there is an increase in published data on cancer treatment by population-based cancer registries over the years. In addition, the review indicates that treatment data are most often collected for breast cancer, the most frequent cancer in women in Europe, followed by colorectal, prostate and lung cancers, which are also more common. Treatment data are increasingly being reported by cancer registries, though further improvements are required to ensure their complete and harmonised collection. Sufficient financial and human resources are needed to collect and analyse treatment data. Clear registration guidelines are to be made available to increase the availability of real-world treatment data in a harmonised way across Europe. Frontiers Media S.A. 2023-02-08 /pmc/articles/PMC9944949/ /pubmed/36845700 http://dx.doi.org/10.3389/fonc.2023.1109978 Text en Copyright © 2023 Giusti, Martos, Trama, Bettio, Sanvisens, Audisio, Arndt, Francisci, Dochez, Ribes, Fernández, Gavin, Gatta, Marcos-Gragera, Lievens, Allemani, De Angelis, Visser, Van Eycken and the ENCR Working Group on Treatment Data Harmonisation https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Giusti, Francesco Martos, Carmen Trama, Annalisa Bettio, Manola Sanvisens, Arantza Audisio, Riccardo Arndt, Volker Francisci, Silvia Dochez, Carine Ribes, Josepa Fernández, Laura Pareja Gavin, Anna Gatta, Gemma Marcos-Gragera, Rafael Lievens, Yolande Allemani, Claudia De Angelis, Roberta Visser, Otto Van Eycken, Liesbet Cancer treatment data available in European cancer registries: Where are we and where are we going? |
title | Cancer treatment data available in European cancer registries: Where are we and where are we going? |
title_full | Cancer treatment data available in European cancer registries: Where are we and where are we going? |
title_fullStr | Cancer treatment data available in European cancer registries: Where are we and where are we going? |
title_full_unstemmed | Cancer treatment data available in European cancer registries: Where are we and where are we going? |
title_short | Cancer treatment data available in European cancer registries: Where are we and where are we going? |
title_sort | cancer treatment data available in european cancer registries: where are we and where are we going? |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944949/ https://www.ncbi.nlm.nih.gov/pubmed/36845700 http://dx.doi.org/10.3389/fonc.2023.1109978 |
work_keys_str_mv | AT giustifrancesco cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT martoscarmen cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT tramaannalisa cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT bettiomanola cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT sanvisensarantza cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT audisioriccardo cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT arndtvolker cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT franciscisilvia cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT dochezcarine cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT ribesjosepa cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT fernandezlaurapareja cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT gavinanna cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT gattagemma cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT marcosgragerarafael cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT lievensyolande cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT allemaniclaudia cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT deangelisroberta cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT visserotto cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT vaneyckenliesbet cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing AT cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing |